课题基金 / 基金详情

PATHOBIOLOGY OF RETROVIRUSES

PATHOBIOLOGY OF RETROVIRUSES
逆转录病毒的病理学
批准号:
2064333
负责人:
Jonathan S Allan
金额:
$38.85万
依托单位国家:
美国
项目类别:
财政年份:
1989
资助国家:
美国
项目状态:
已结题
起止时间:
1989-03-01 至 1997-02-28

项目摘要

项目成果

Jonathan S Allan的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: (Adapted from applicant's abstract) The investigator has two specific aims. The first is to study genetic diversity and phylogeny among naturally-occurring SIVs from African non-human primates. The author will attempt to more rigorously define viral evolution and divergence of SIVagm (SIV in African Green Monkeys) viruses in relation to their host species. Full-length clones of SIVagm(sab) from West African green monkeys and SIVagm(tan) from tantalus monkeys will be sequenced and compared with two other species of African green monkeys (vervet and grivets). Additional SIVagm (gri) and SIVabm(ver) viruses will be analyzed to determine whether species-specific SIVagm viruses from vervet, grivet, sabaeus and tantalus monkeys have evolved and diverged coincident with their respective host species. In addition, the author will expand genetic studies to include viruses from other monkey species within the Cercopithecus genus, including Patas and Hamlyn's monkeys. The second goal of the investigator is to define and compare viral and host determinants of pathogenesis for naturally-occurring SIVs. The purpose of this aim is to define viral and host factors which play a role in determining natural resistance to disease. Certain strains of SIVagm may be more pathogenic than others. The study of more pathogenic strains of SIVagm strains may lead to the identification of specific determinants directly involved in pathogenesis. Both molecular and biologic clones derived from green monkeys with SIV-related abnormalities will be further studied in the green monkey animal model.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DETERMINANTS OF NATURAL HOST RESISTANCE TO SIV AGM
DETERMINANTS OF NATURAL HOST RESISTANCE TO SIV AGM
DETERMINANTS OF NATURAL HOST RESISTANCE TO SIV AGM
CHEMOKINE RECEPTORS AND NATURAL HOST RESISTANCE TO SIV
海外基金